5050 Nathan Lane
Booth #: 03A
At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world — in nutrition, diagnostics, medical devices and branded generic pharmaceuticals — that create more possibilities for more people at all stages of life. Today, 94,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.
17300 Transcanada Highway
Booth #: 03
In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an oral anticoagulant discovered by Bristol-Myers Squibb. This global alliance combines Bristol-Myers Squibb's long-standing strengths in cardiovascular drug development and commercialization with Pfizer's global scale and expertise in this field.
2F 3-27-11 Shibuya Shibuya-ku
Allm Inc. is a leading Japanese company with an ecosystem-platform of communication with the maximization of cloud and smart devices, enabling seamless information flow among the healthcare professionals. A super network of knowledge and experience will support these professionals decision, anywhere and anytime.
American Heart Association/
American Stroke Association
7272 Greenville Avenue
Booth #: 23
The American Heart Association/American Stroke Association – building healthier lives, free of cardiovascular diseases and stroke. Learn more about the AHA/ASA, its programs, and one of its journals – Stroke. Stroke is a top-ranked journal in its field and publishes articles focused on clinical and basic investigation of any aspect of the cerebral circulation and its diseases from many disciplines (neurology, neuropathology, neurosurgery, vascular surgery, rehabilitation, critical care medicine, vascular physiology, radiology, nursing). Visit https://professional.heart.org or https://stroke.ahajournals.org. "Like" our Facebook page (Stroke-AHA/ ASA) or follow us on Twitter (@StrokeAHA_ASA). Review the latest journal metrics at https://www.ahajournals.org/content/metrics.
Binger Strasse 173
Ingelheim am Rhein
Booth #: 18
The European Angels initiative is a non-promotional, pan-European health care initiative by Boehringer Ingelheim International GmbH endorsed by the European Stroke Organisation to assist in implementing its main goal, to improve the stroke care across Europe. The Angels Initiative is supported by Medtronic.
2920 Matheson Blvd. East
Bayer is an innovation company with a more than 150-year history and core competencies in the fields of health care and agriculture. We develop new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen.
225 Binney Street
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. One of the world's first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp, and today has the leading portfolio of medicines to treat multiple sclerosis; has introduced the first and only approved treatment for spinal muscular atrophy; and is focused on advancing neuroscience research programs in Alzheimer's disease and dementia, multiple sclerosis and neuroimmunology, movement disorders,
BKIN Technologies Ltd
140 Railway Street
Booth #: 24
KINARM Labs™ provide robust and objective measures of brain function and dysfunction by the precise measurement of human behaviour with robotics. Created by neuroscientists, KINARM Labs allow clinician-scientists to detect and quantify the sensory, motor and cognitive impact of a diverse range neurological impairments caused by stroke, cardiac arrest, TIA, mTBI, concussion, MS or Parkinson's - all in a short <1h assessment. KINARM is an essential tool in the personalization of new CNS therapies. On site you will be able to experience a KINARM Exoskeleton Lab used recently in a clinical trial for a new stroke drug.
Binger Str. 173
Booth #: 07
Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients' lives. In animal health, Boehringer Ingelheim stands for advanced prevention. Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals.
Suites 11-14, 263 Banbury Rd
Booth #: 06
Brainomix Limited, a medical diagnostics software company is dedicated to improving outcomes for patients with neurological and cerebrovascular disorders. Using Artificial Intelligence and Large Data Analytics it is developing and equipping physicians with world-class medical imaging software. Brainomix aims to help them in making life-saving treatment decisions by supporting the selection of the right stroke treatment for the right patient.
BMS Pfizer Alliance
3401 Princeton Pike
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Canadian Stroke Consortium
101-2275 Upper Middle Road East
Booth #: 03B
Created, owned and operated by its members, the Canadian Stroke Consortium (CSC) was established in 1993 and incorporated as a non-profit organization in 1996. Today, we are the national professional association for physicians interested in stroke. Our associate members are colleagues who represent other disciplines involved in stroke prevention and treatment. Together, we are committed to reducing the burden of stroke through the translation of clinical research into clinical practice. Composed of 15 actively enrolling Canadian stroke centers, CSC leads the design and implementation of clinical research activities and educational initiatives that contribute to improving clinical stroke care in Canada.
501, 10154 104 Street NW
Booth #: 20
Through accreditation, CARF advances excellence in stroke specialty programs by assisting providers in improving the quality of their services, demonstrating value, and meeting internationally recognized organizational and program standards. CARF standards assess an organization's ability to meet or exceed standards for business practices as well as specific service delivery standards such as those aimed at minimizing impairments and complications, reducing activity limitations, maximizing participation and quality of life, decreasing environmental barriers, and preventing recurrent stroke. For more information, call at 1-888-281-6531 or visit www.carf.org.
33 Technology Drive
Booth #: 17
CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, is a global leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke.
EVER Neuro Pharma GmbH
Booth #: 13
We are a globally successful pharmaceutical specialist. At our headquarters in Unterach, Austria, we are always on the search for new therapeutic solutions aimed at improving both the patients' well-being and quality of life. Cerebrolysin® is a biotechnologically manufactured original neuropeptide solution that stimulates neurotrophic regulation in the central nervous system. It is indicated for the treatment of stroke, traumatic brain injuries and cognitive impairment/dementia. Tachyben is used for intravenous treatment of hypertensive emergencies. It is used to control lowering of blood pressure in hypertensive patients during and/or after surgery in cases of severe forms of hypertensive disease.
5th European Stroke Organisation Conference
ESOC 2019 SECRETARIAT: Rue François-Versonnex 7
Booth #: 03C
ESOC 2019 - The Voice of Stroke in Europe The European Stroke Organisation Conference is the premier European forum for stroke research and rapidly becoming the world's foremost platform for the release of major trial data.
If you don't already have a placeholder in your diary for this important event, we encourage you to do so. Not only will this leading conference enhance your knowledge and practice, it will provide you with a unique opportunity to network with a wide range of professionals in the field of stroke.
Join us in Milan, Italy on 22-24 May 2019.
Firstkind Ltd Hawk House, Peregrine Business Park, Gomm Road
Booth #: 27
Firstkind has worked with The University Hospital of North Midlands NHS Trust in the UK to introduce geko™ into the stroke pathway when patients are unsuitable for drug prophylaxis and/or contraindicated or intolerant to IPC. Interim analysis highlights that the majority of high risk immobile acute stroke patients who could not tolerate IPC tolerated the geko™ device. These patients would have not been treated as effectively otherwise, with the potential that geko™ will reduce the risk of morbidity and mortality in stroke patients. Please visit stand 27 to find out more.
Image Monitoring Inc
3184 Ridgeway Dr. Units 43-44
Booth #: 25
Image Monitoring Inc. has been distributing innovative medical instrumentation to the Canadian medical community for over 27 years. We specialize in Cardiac, Vascular, Cardio pulmonary and Imaging disciplines. Image Monitoring is proud to represent Viasonix, NorthEast Monitoring, Norav, IEM, , Cortex, and many more
International Society on Thrombosis
and Haemostasis (ISTH)
610 Jones Ferry Road, Suite 205
Booth #: 26
The International Society on Thrombosis and Haemostasis (ISTH) is a global not-for-profit membership organization advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. The Society is dedicated to transformative scientific discoveries and clinical practices, the development of young professionals and the education of physicians, scientists and allied health professionals wherever they may live. At the ISTH, we initiate and promote education and outreach initiatives, research activities, scientific meetings, peer-reviewed publications, expert committees and the development of standards allowing a common language and approach to basic and clinical science all over the world.
7402 Hollister Avenue
Booth #: 29
InTouch Health, the 2018 Best in KLAS Category Leader for Virtual Care Platforms, is a telehealth services company that offers health systems a full range of solutions to efficiently deliver Consumer, Specialty, and Emergent virtual care for any care environment. InTouch Health provides the most reliable, dedicated cloud-based network and virtual care solutions that ensure connectivity for health systems, providers, and patients at all times. Today, InTouch Health supports more than 2,250 care locations around the world – including many of the top 20 health systems –as they deploy telehealth programs across their enterprises. To learn more, please visit www.intouchhealth.com.
405 El Camino Real, Suite 601
Booth #: 15A
is the leader in cerebrovascular imaging analysis. RAPID is the most advanced
brain imaging platform and has been validated in early and late window stroke
trials including SWIFT PRIME, EXTEND IA, DAWN and DEFUSE 3. These studies used
RAPID to select patients for thrombectomy and achieved the best clinical
outcomes and largest treatment effects ever obtained. These landmark studies led to new American
Heart Association guidelines and have dramatically altered the management of
acute stroke around the world.
March of Dimes Canada
10 Overlea Blvd
Booth #: 30
March of Dimes Canada is a nationally registered charitable organization providing support services to people with physical disabilities, their families and caregivers across Canada. Our goal is to enhance the independence and community participation of people with physical disabilities every day through a wide range of programs and services across Canada. For more information, please visit www.marchofdimes.ca or call 1-800-263-3463.
Medtronic 9775 Toledo Way
Booth #: 04
As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations and the burden of chronic disease — faced by families and healthcare systems today. But, we can't do it alone. That's why we're committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes. Join us in our commitment to take healthcare Further, Together. Learn more at Medtronic.com.
One Penumbra Place
Booth #: 14
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals and clinics primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc.
270 E Grand Ave
South San Francisco
Booth #: 13A
Portola Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic diseases. The Company's two FDA-approved medicines are Bevyxxa® (betrixaban) and Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo. The company also is advancing cerdulatinib, a Syk/JAK inhibitor for hematologic cancers
1 Oliver's Yard
Booth #: 22
Sara Miller McCune founded SAGE Publishing in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE publishes more than 1,000 journals and over 800 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company's continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. www.sagepublishing.com
14 Electronics Ave
Booth #: 01
NeuroLogica, the healthcare subsidiary of Samsung Electronics, develops and manufactures innovative imaging technologies and is committed to delivering fast, easy, and accurate diagnostic solutions to healthcare providers. We are the global headquarters and manufacturer of computed tomography (CT). Our advanced medical technologies are used worldwide in leading healthcare institutions, helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency.
235 boul. Armand-Frappier
Booth #: 02
Servier is an international pharmaceutical company governed by a non-profit foundation with its headquarters in Suresnes (France). With a strong international presence in 148 countries, Servier employs 21 000 people worldwide. Corporate growth is driven by Servier's constant search for innovation in five areas of excellence: cardiovascular diseases, diabetes, cancers, immune-inflammatory diseases, and neurodegenerative diseases. Being completely independent, the Group reinvests 25% of turnover in research and development and uses all its profits for growth.
Stroke Alliance for Europe
Stroke Association House, 240 City Road
Booth #: 21
SAFE is an umbrella organisation of stroke support organisations (SSO) throughout Europe. Its vision is to work towards greatly decreasing the number of strokes in Europe and that all who are touched by stroke get the help and support they need. SAFE therefore engages in activities such as helping in the creation and strengthening of SSOs, campaigning, education and encouraging research which contributes to the advancement of stroke prevention and the improvement of the quality of life of stroke survivors, their families and carers. The overall aim of SAFE is to reduce the numbers of, and ameliorate the effects of,
47900 Bayside Parkway
Booth #: 08
Stryker is one of the world's leading medical technology companies and, together with our customers, is driven to make healthcare better. We offer innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
World Stroke Organization
Rue Francois Versonnex 7
Booth #: 16
The World Stroke Organization (WSO) is the world's leading organization in the fight against stroke. It was established in October 2006 through the merger of the International Stroke Society and the World Stroke Federation with the purpose of creating one world voice for stroke. Today, WSO has more than 4000 individual members and over 60 society members from 85 different countries.